Tizanidine
- Product NDC
- 60760-719
- 11-digit product format
- 607600719
- Labeler code
- 60760
- Product ID
- 60760-719_cdb5c18b-079c-aad1-e053-2a95a90a0b0c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- St. Mary's Medical Park Pharmacy
- Application
- ANDA076416
- Marketing category
- ANDA
- Marketing start
- 2021-07-27
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 60760-719 | TIZANIDINE TABLET [ST. MARY'S MEDICAL PARK PHARMACY] | 3 | Legacy NDC | 20241215_c8adf7df-53be-9aff-e053-2995a90a8ec1.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60760-719-04 | 60760071904 | 4 TABLET in 1 BOTTLE, PLASTIC (60760-719-04) | 4 tablet | 2021-07-27 | 0000-00-00 | No | No | Current |
| 60760-719-15 | 60760071915 | 15 TABLET in 1 BOTTLE, PLASTIC (60760-719-15) | 15 tablet | 2021-09-29 | 0000-00-00 | No | No | Current |